Company Filing History:
Years Active: 2013-2019
Title: Michael A. Perricone: Innovator in Peptide Research
Introduction
Michael A. Perricone is a notable inventor based in Sudbury, MA (US). He has made significant contributions to the field of peptide research, particularly in the development of peptide analogs of alpha-melanocyte stimulating hormone. With a total of 4 patents to his name, Perricone's work has implications for both medical and veterinary applications.
Latest Patents
Perricone's latest patents focus on stable peptide analogs of the native alpha-melanocyte stimulating hormone (α-MSH). These analogs exhibit selectivity for the melanocortin 1 receptor (MC1R). The patents also include pharmaceutical preparations of the α-MSH peptide analogs, along with methods for utilizing these analogs in treating various medical and veterinary conditions involving MC1R.
Career Highlights
Michael A. Perricone is associated with Genzyme Corporation, where he continues to advance his research in peptide analogs. His work has garnered attention for its potential therapeutic applications, showcasing his commitment to innovation in the field.
Collaborations
Perricone has collaborated with notable colleagues, including John Lyle Dzuris and Timothy E. Weeden. These partnerships have contributed to the development and refinement of his research projects.
Conclusion
Michael A. Perricone stands out as an influential inventor in the realm of peptide research, with a focus on innovative solutions for medical and veterinary challenges. His contributions continue to shape the future of peptide therapeutics.